Pregled bibliografske jedinice broj: 747671
Systematic transfusion treatment surveillance in Croatia
Systematic transfusion treatment surveillance in Croatia // Vox Sanguinis
Seoul, Republika Koreja, 2014. str. 222-222 (poster, međunarodna recenzija, sažetak, ostalo)
CROSBI ID: 747671 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Systematic transfusion treatment surveillance in Croatia
Autori
Šarlija, Dorotea ; Štimac, Ružica ; Vuk, Tomislav ; Jukić, Irena
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
Vox Sanguinis
/ - , 2014, 222-222
Skup
33st International Congress of the ISBT
Mjesto i datum
Seoul, Republika Koreja, 31.05.2014. - 05.06.2014
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
systematic transfusion treatment surveillance; transfusion reactions
Sažetak
Background: A voluntary system of transfusion reaction monitoring has been present in Croatia since 1999. As the Croatian legislative related to blood and blood products was harmonized with European Council Directives in 2006, establishment of the blood product traceability system and the national system of reporting adverse and unexpected events has become necessary. The Croatian Institute of Transfusion Medicine (CITM) performs Systematic Surveillance of Transfusion Treatment (SSTT) at the national level, i.e. data collection, assessment and categorization of reactions/events, data processing and reporting to the Ministry of Health. Healthcare institutions using blood products in transfusion treatment systematically record, assess and manage reactions, and report all reactions/events in the form of annual report directly to CITM or through their transfusion units. In case of a serious adverse event (SAE) or serious adverse reaction (SAR), healthcare institution reports it in writing to CITM or Ministry of Health within 24 hours. Aims: SSTT collects data on patient transfusion reactions, adverse events and reactions/complications recorded in blood donors. Methods: Reactions to transfusion treatment are classified according to the Proposed Standard Definitions for Surveillance of Non Infectious Adverse Transfusion Reactions (ISBT, IHN, 2011), while their prevalence is expressed per number of units issued for transfusion treatment. Events are classified according to the Medical Event Reporting System for Transfusion Medicine. Reactions/complications in blood donors are classified according to the Standards for Collecting and Reporting Data on Reactions Related to Blood Donation (EHN, ISBT, 2008), and their prevalence is expressed per number of blood donations. Results: Since 2010, the SSTT annual report is published in the Croatian Transfusion Gazette. During the 2010-2012 period, the prevalence of transfusion reactions was 1.2/1000, of which 0.08/1000 reactions were characterized as SAR. A total of 716 adverse events were reported, 186 of the characterized as SAE by subsequent evaluation, mostly due to human error. Out of 12.4/1000 reactions reported in blood donors, 0.12/1000 were characterized as SAR. Summary: SSTT requires continuous education of all professionals involved, including transfusiologists, physicians and nurses at clinical wards, in order to properly recognize and manage reactions, analyze reactions/events, and determine corrective/preventive measures. It is of utmost importance for hospital specialists in transfusion medicine to take active part in these processes through their engagement in hospital boards for transfusion treatment. We plan to introduce reaction/event reporting via e-Delphyn, unique national transfusion software, whereas the SSTT annual report will be upgraded with additional analysis and recommendations.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE